RxDoctor Payments Data

Robert Hosse, MD

Pulmonary Disease · Baton Rouge, LANPI 1447791686

Payments from drug & device makers

$409in general payments, 2019–2025

Across 19 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Grifols USA, LLC$52
  • Insmed, Inc.$45
  • Boehringer Ingelheim$40
  • AstraZeneca$39
  • Sanofi$37
  • AbbVie$31
  • plus $164 from 8 others

What the payments were for

  • Food & beverage$39196%
  • Education$174%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$409 in reported general payments places this provider in the 20th percentile of 189 pulmonary disease providers in Louisiana.

See all pulmonary disease providers in Louisiana

Medicare billing

Part B allowed, 2024
$33,369
Medicare patients
73
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →